The Scientist

» biotechnology and immunology

Most Recent

image: Novel Hantavirus Infection Method

Novel Hantavirus Infection Method

By | July 3, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: Brrrr-ying the Results

Brrrr-ying the Results

By | July 1, 2015

Holding laboratory mice at temperatures lower than those the animals prefer could be altering their physiology and skewing experimental results.

1 Comment

image: Diagnosing Ebola in 15 Minutes

Diagnosing Ebola in 15 Minutes

By | June 30, 2015

A new test that scans for the Ebola virus with just a fingerprick could be a practical diagnostic for use in West Africa.

0 Comments

image: Sex Differences in Pain Pathway

Sex Differences in Pain Pathway

By | June 29, 2015

Male and female mice utilize different immune cells to process pain, a study shows.

1 Comment

image: Celladon Shutters Its R&D

Celladon Shutters Its R&D

By | June 26, 2015

Biotech firm likely to pull the plug after its gene therapy product fails.

0 Comments

image: Week in Review: June 22–26

Week in Review: June 22–26

By | June 26, 2015

Neanderthal-human hybrid discovered; the neurobiology of fear behavior; and an insulin patch that responds to high glucose levels in mice

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

image: Neutralizing HIV

Neutralizing HIV

By | June 18, 2015

Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.

0 Comments

image: Optogenetics Meets CRISPR

Optogenetics Meets CRISPR

By | June 15, 2015

Researchers in Japan have developed a photoactivatable Cas9 nuclease to control CRISPR-based gene editing with the flip of a switch.

0 Comments

Popular Now

  1. Students Study Their Own Microbiomes
  2. Single Bacterial Species Improves Autism-Like Behavior in Mice
  3. Illustrating #FieldworkFails
  4. Transmissible Cancers Plague Mollusks
Biosearch Technologies